Register entry
Servier Pharmaceuticals LLC
- Registered sites
- 0
- Drug products
- 5
- Live patents
- 20
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
20Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| TIBSOVO | IVOSIDENIB | Jun 2030 |
| TIBSOVO | IVOSIDENIB | Jan 2033 |
| TIBSOVO | IVOSIDENIB | Aug 2033 |
| TIBSOVO | IVOSIDENIB | Mar 2035 |
| TIBSOVO | IVOSIDENIB | Oct 2036 |
| TIBSOVO | IVOSIDENIB | Jun 2039 |
| VORANIGO | VORASIDENIB | Jul 2034 |
| VORANIGO | VORASIDENIB | Dec 2035 |
| VORANIGO | VORASIDENIB | Jan 2039 |
Catalogue
Marketed products
5Showing 5 of 5.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| ONCASPAR | Pegaspargase | INJECTION, SOLUTION | BLA |
| TIBSOVO | ivosidenib | TABLET, FILM COATED | NDA |
| VORANIGO | vorasidenib | TABLET, FILM COATED | NDA |
| VORANIGO | vorasidenib | TABLET, FILM COATED | NDA |
| asparlas | calaspargase pegol | INJECTION, SOLUTION | BLA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.